|Bid||0.4804 x 4000|
|Ask||0.4964 x 3200|
|Day's range||0.4790 - 0.5100|
|52-week range||0.4100 - 1.2050|
|Beta (5Y monthly)||2.91|
|PE ratio (TTM)||N/A|
|Earnings date||09 Nov 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||2.78|
If you're a fan of investing in turnaround plays, Aurora Cannabis (NASDAQ: ACB) is a stock that you should probably know about. Aurora shareholders have had a (very) rough few years. Multiple factors are to blame, starting with its now-abandoned leave-no-customer-behind strategy, wherein it seriously overbuilt its cannabis production capacity as well as its retail footprint in an attempt to seize as much of the Canadian marijuana market as possible.
There just might be light at the end of the long, dark tunnel for this beleaguered cannabis company.
In recent years, Aurora Cannabis (NASDAQ: ACB) has been trying to slash expenses wherever it could to improve its cash flow and bottom line. This has included closing facilities, cutting staff, and ultimately reducing its position in the consumer cannabis market in Canada. The efforts have been paying off, as the company has posted stronger results of late, including positive adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) for four consecutive quarters.